Christopher Perry

Christopher Perry is a seasoned professional specializing in bioprocess development, currently serving as the Downstream Process Development Team Lead at Rentschler Biopharma SE since January 2022. In this role, Christopher leads downstream activities for client projects and bioprocess development of lentiviral and AAV vectors, while overseeing junior and senior scientists' training and resource allocation. Prior experience includes positions at Autolus Ltd. as a Senior Scientist and at University College London, where Christopher designed and executed innovative experiments in bioprocessing and analytics. Academic credentials include an EngD and MSc in Biochemical Engineering from UCL and a BSc in Biochemistry from the University of Surrey. Christopher is well-versed in technical discussions with stakeholders and has a strong background in process development and regulatory compliance.